GlassScriptPhysician profile
Chantal P Baptiste
NPI 1851867766
$19,190.24
in general payments reported to CMS, 2019-2025
39 companies · $5,472 in 2025
The $5,472 reported for 2025 was more than what 99% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $677 · 2022: $4,284 · 2023: $4,513 · 2024: $4,245 · 2025: $5,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,105.31 |
| Education | $123.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,596.26 | 2022-2025 | Austedo Xr, Uzedy, Austedo |
| Neurocrine Biosciences, INC. | $2,465.20 | 2022-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $1,934.60 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Alkermes, INC. | $1,726.06 | 2021-2025 | Lybalvi, Aristada |
| Janssen Pharmaceuticals, INC | $1,493.91 | 2022-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,285.12 | 2021-2025 | Caplyta |
| Abbvie INC. | $1,059.16 | 2022-2025 | |
| Vanda Pharmaceuticals INC. | $847.61 | 2021-2025 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $720.59 | 2022-2025 | Auvelity |
| Gilead Sciences, INC. | $455.22 | 2021-2025 | Livdelzi, Epclusa |
| Lundbeck LLC | $402.07 | 2022-2025 | Rexulti |
| Indivior INC. | $389.31 | 2022-2024 | Perseris, Sublocade |
| Novo Nordisk INC | $340.36 | 2024-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $327.62 | 2024-2025 | Cobenfy |
| Medtronic, INC. | $304.56 | 2025 | Symplicity G3 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chantal Baptiste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.